An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
一项适应性 II/III 期安全性和有效性随机对照试验，比较单日或三日固定剂量阿苯达唑-伊维菌素复方制剂与阿苯达唑治疗鞭虫病和其他土源性线虫感染的疗效。ALIVE 试验方案
期刊:Gates Open Research
影响因子:
doi:10.12688/gatesopenres.13615.1
Krolewiecki, Alejandro; Enbiale, Wendemagegn; Gandasegui, Javier; van Lieshout, Lisette; Kepha, Stella; Messa Junior, Augusto; Bengtson, Michel; Gelaye, Woyneshet; Escola, Valdemiro; Martinez-Valladares, María; Cambra-Pellejà, María; Algorta, Jaime; Martí-Soler, Helena; Fleitas, Pedro; Ballester, Maria Rosa; Doyle, Stephen R; Williams, Nana Aba; Legarda, Almudena; Mandomando, Inácio; Mwandawiro, Charles; Muñoz, José
